Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. - Wikidata - awgldk - TriplyDB

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.

http://www.wikidata.org/entity/Q51784332

about

Posttranslational Modifications and the Immunogenicity of Biotherapeutics Potential Mechanisms for IgG4 Inhibition of Immediate Hypersensitivity Reactions Alloantibody Generation and Effector Function Following Sensitization to Human Leukocyte Antigen IgG4 Characteristics and Functions in Cancer Immunity Influence of immunoglobulin isotype on therapeutic antibody function TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity Human IgG4: a structural perspective Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases Principles of antibody-mediated TNF receptor activation NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy Cross-presentation of IgG-containing immune complexes A perspective on the structure and receptor binding properties of immunoglobulin G Fc The Role of FcRn in Antigen Presentation Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms.Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtype Crystal Structure of Fc Receptor I and Its Implication in High Affinity -Immunoglobulin Binding Selective Deactivation of Serum IgG: A General Strategy for the Enhancement of Monoclonal Antibody Receptor Interactions Structural Determinants of Unique Properties of Human IgG4-Fc Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab Immune recruitment or suppression by glycan engineering of endogenous and therapeutic antibodies Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation Fc gamma receptors: glycobiology and therapeutic prospects Advances in Therapeutic Fc Engineering - Modulation of IgG-Associated Effector Functions and Serum Half-life Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity IgG antibodies to cyclic citrullinated peptides exhibit profiles specific in terms of IgG subclasses, Fc-glycans and a fab-Peptide sequence IgE-based Immunotherapy of Cancer -A Comparative Oncology Approach Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease.CD16 and CD32 Gene Polymorphisms May Contribute to Risk of Idiopathic Thrombocytopenic Purpura.The Fab conformations in the solution structure of human immunoglobulin G4 (IgG4) restrict access to its Fc region: implications for functional activity Dimeric FcγR Ectodomains as Probes of the Fc Receptor Function of Anti-Influenza Virus IgG.Broadly Neutralizing Hemagglutinin Stalk-Specific Antibodies Induce Potent Phagocytosis of Immune Complexes by Neutrophils in an Fc-Dependent Manner.Antigen reversal identifies targets of opsonizing IgGs against pregnancy-associated malaria Mechanisms of action of intravenous immunoglobulins.FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian population.H435-containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: implications for alloantibody-mediated diseases of the newborn.Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases.Murine IgG1 and IgG3 isotype switch variants promote phagocytosis of Cryptococcus neoformans through different receptors Comparison of gene expression profiles between human and mouse monocyte subsets

P2860

Q26748614-6C195FBF-30CC-4D82-8DD4-B90CAE9DEBD2 Q26764848-BDBB919A-FEB9-443C-98A6-693AD9F0FCAA Q26766411-B12761C7-68AD-463C-A747-A5E71224FD1D Q26770244-B6F5264F-FCAA-4A48-9CD9-43B1F5881058 Q26772080-ABC0C0A4-24AE-4393-AFBF-D72885A1EFCB Q26779753-AC992F04-DDAA-4FF1-A53D-9A2DDFACAABF Q26779758-D69C5C14-1AA6-4573-88AA-C1F6263F780C Q26783175-F8EF3EEE-7FAB-4DD8-A772-7816DD02838E Q26796270-ED8B7E14-0F3C-49AC-9B6A-6845F0903001 Q26797345-0A44DF09-8A39-4340-9727-D2E6AD4374E5 Q26825801-63A5AEEC-F5DE-4794-8B91-393DFE903850 Q26827579-9AF6099C-4189-45EF-A06F-B26A807B62F9 Q26852988-7B03CAFF-6B7E-4A7F-A2FC-40A2A0801D88 Q27314948-C02338A8-80D3-46C0-B0D5-78289FCCEE74 Q27490436-E2CBD556-070B-4B60-83A5-11D80125059E Q27674690-E0F10F49-7DC0-4C78-8C79-CCEFDA48BAEF Q27678384-7619881C-F428-469C-B1F1-163A736C3A5F Q27680566-7076F752-7557-4477-B10F-A02AB80B7C4F Q27702872-50A60A48-6721-494B-BCEC-E0FA30FA4BA2 Q28069362-58A48906-42F2-45CE-8B9B-49A1CB7F1411 Q28072319-E8DB6E94-CD34-43CE-9235-0EC2C64DFB38 Q28076193-92C752E7-1772-4ABA-9EA3-F9BC000FA0E6 Q28076303-ACF779D6-F40C-4924-8632-7BA8E905EABB Q28079016-FFF6D1F4-AE42-40C2-879A-93FBC8B0D3C3 Q28085328-DFB71707-913D-4A6B-A492-03B1382C689E Q28545233-785FF313-4EE8-4E66-B557-8A531774249A Q28655505-68792985-AAEE-45CC-9C4D-4CB6B7E5677C Q29417017-D9725FF1-D5D4-4B6A-9DCA-DF39CF040B47 Q30249541-A7F6900D-80D7-4845-93FC-241F924927DD Q30363006-C75F3359-18CB-4FF8-A9E0-B0A3951A1D6F Q30390233-246EAE1E-C34C-4BE9-B9EB-58A4003D09DC Q30393724-EAECE37F-91D0-47FA-B9DE-0FCD73802CBD Q30603697-EEA7ADD7-53E3-4693-A786-493D658B1795 Q33389428-26EDF919-39B4-4DD6-B815-87858B199B0F Q33403638-5574EFA6-55E8-4CF2-8E0C-A272D270077F Q33408913-56ED0108-E89E-4222-A2A9-1D1CB7DF7CE8 Q33411525-953BC7F4-92F4-4735-AEAB-AD2842E18EB0 Q33430624-53B036C0-E6EC-463E-A649-6B12B8048F5B Q33562297-18D4AB86-90AD-43AB-A2C4-8FE3F2385819 Q33608738-46BE5771-5EB9-4153-B8D1-07E3B9700D54

P2860

Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses.

http://www.wikidata.org/entity/Q51784332

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Specificity and affinity of hu ...... ants for human IgG subclasses.

@en

Specificity and affinity of hu ...... ants for human IgG subclasses.

@nl

type

label

Specificity and affinity of hu ...... ants for human IgG subclasses.

@en

Specificity and affinity of hu ...... ants for human IgG subclasses.

@nl

prefLabel

Specificity and affinity of hu ...... ants for human IgG subclasses.

@en

Specificity and affinity of hu ...... ants for human IgG subclasses.

@nl

P1433

Q51784332-7DA81A78-3442-4931-BB05-C9CA1E6D7E74

P1476

Q51784332-5EF4D948-7C81-41CA-80FA-2615312B008F

P2093

Q51784332-49369938-68BB-41DE-9DB7-9DE5C7390742

Q51784332-85AF8B5C-130C-4311-94D9-98EA1C0550D3

Q51784332-8BD856E6-2E4A-4512-8E61-C61783888391

Q51784332-9C7784E6-040C-4F20-8737-47DE0780A807

Q51784332-E0358591-3F83-45F2-989E-3014C17E0C42

Q51784332-E4ED4B77-51EB-4576-9FA6-A4945AC2EBB8

Q51784332-F1CB9A5E-7D4D-42BC-A038-3A4FF4D88DE7

P304

Q51784332-D3EC7108-7CD7-400E-87B6-767723A46C24

P31

Q51784332-4958A1F6-8196-4332-803B-F6D65F46572A

P356

Q51784332-5F96A5C2-EF17-4BA5-8413-0B12AE322C97

P407

Q51784332-8487036C-8E03-4ADD-836D-2FB0D96A2E61

P433

Q51784332-2046AB0C-8DA7-4AB4-AEB8-E334260A1271

P478

Q51784332-FE05C1FF-C260-4463-8D09-0CFE1114E3FF

P577

Q51784332-446A3104-1B50-4DE3-B0DD-05D78439D44C

P5875

Q51784332-BCCDA9A0-D335-49C7-9E07-558125519832

P698

Q51784332-E97E9C80-C119-4F19-A9DE-651AB6A63AC1

P356

BLOOD-2008-09-179754

P1433

P1476

Specificity and affinity of hu ...... ants for human IgG subclasses.

@en

P2093

Bruno Iannascoli

http://www.w3.org/2001/XMLSchema#string

David A Mancardi

http://www.w3.org/2001/XMLSchema#string

Marc Daëron

http://www.w3.org/2001/XMLSchema#string

Nadine Fernandez

http://www.w3.org/2001/XMLSchema#string

Patrick England

http://www.w3.org/2001/XMLSchema#string

Pierre Bruhns

http://www.w3.org/2001/XMLSchema#string

Sylvie Jorieux

http://www.w3.org/2001/XMLSchema#string

P304

3716-3725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-09-179754

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23482309

http://www.w3.org/2001/XMLSchema#string

P698

19018092

http://www.w3.org/2001/XMLSchema#string